Laitai Company is a modern high-tech enterprise that integrates drug research and development, production, and sales. Its predecessor was Guangzhou Shanhe Pharmaceutical Factory established in 1992 and in 1998 ..

Publicize authoritative certifications and technological awards, verify the compliance of quality systems and research and development capabilities, enhance drug trust and industry cooperation confidence

Linking the growth trajectory of enterprises with milestone events, verifying the continuity of technological accumulation and quality commitments, and enhancing the public's historical trust and endorsement of drug safety and reliability

Promote the value concept of quality first, standardize employee behavior standards, strengthen the GMP compliance awareness of all employees, and provide internal guarantees for drug safety and reliability

Proactively disclose research and development progress and quality milestones, timely convey drug regulatory dynamics and safety measures, strengthen the responsibility for transparent management of the entire drug process

By visualizing images to demonstrate the implementation of GMP standards, conveying quality control details intuitively, enhancing patients' trust in drug safety, and improving industry compliance transparency

Publicize pharmaceutical and health public welfare practices, fulfill corporate social responsibility, benefit vulnerable groups through free drug assistance and disease education, and convey brand warmth and social value

By showcasing the compliance hardware and rigorous quality control processes of intelligent factories through real-life scenarios, the production assurance system for drug safety and reliability is supported by a visual evidence chain

Strictly control the quality of medicinal materials at the source, publicize standardized planting and production processing procedures, ensure the safety and effectiveness of raw materials, and provide the first line of scientific defense for drug efficacy

Publicize the core technology platform and innovation pipeline, demonstrate the scientific and compliant nature of drug research and development, enhance the trust of doctors and patients in efficacy and safety, and attract industry university research cooperation

Publicize authoritative quality system certifications at home and abroad, demonstrate compliance and control capabilities throughout the entire production process, enhance user confidence in medication and trust in medical prescriptions

Collect adverse drug reaction information in accordance with the law, monitor medication risks in real time, protect patients' lives and health through scientific assessment and early warning, and fulfill the main responsibility of drug safety

Publicize the national basic drug production and supply guarantee system in accordance with the law, strengthen the commitment to the accessibility of medicines for people's livelihoods, and simultaneously meet the needs of national drug policies and grassroots medical care

Publicize the supply guarantee of winning products in national negotiations/centralized procurement, convey the commitment to quality assurance and affordable prices for people's livelihoods, and fulfill the policy responsibility of basic medical accessibility

Accurately convey the values of enterprise talents (such as rigor and innovation), attract high-quality talents with strong compliance awareness and professional matching, and ensure the continuity, stability, and compliance of drug research and development production

Build a platform for integrating industry, academia, and research, open up research and production positions, and invite university students to join us in promoting pharmaceutical innovation and ensuring drug quality and safety.

We sincerely invite industry elites to join us, quickly strengthen key positions in research and development and production, jointly overcome technical bottlenecks, and use mature experience to ensure the compliance and quality safety of the entire drug chain

This column provides a public consultation channel, collects medication feedback, connects with cooperation needs, strengthens corporate transparency and trust

The social security information feedback aims to actively collect public medication safety hazards, respond quickly, prevent the spread of drug safety risks, and safeguard public health